IV Equipment Market Outlook (2022-2033)

Increasing Prevalence of Chronic Diseases

Increasing burden of chronic diseases, significantly increases the demand for intravenous therapies relying on specialized equipment such as infusion pumps, IV catheters, and administration sets. Chronic diseases, including cardiovascular diseases, diabetes, and cancer, often require repeated or long-term fluid, medication, and nutritional infusions as part of a regimen of treatment protocols. Because intravenous therapy remains a mainstay of patient care globally, many industry analyses demonstrate that as the incidence of these non-communicative diseases increases, so too does healthcare utilization and the need for reliable IV delivery systems; for instance, it is demonstrated that 71% of global deaths are due to chronic diseases, indicating an ever-expanding population reliant on such therapies. Moreover, with an aging population, the prevalence of age-related chronic conditions further amplifies this effect, resulting in continued demand for IV equipment within both hospitals, clinics, and home healthcare settings. It is expected that new or enhanced IV technologies will fuel demand, hence underlining the leading role of chronic disease as a factor in market growth.

Rapid Expansion of Home-Based Healthcare Services and Smart Infusion Technologies

Home-based healthcare service and smart infusion technology activation is the result of changing the care delivery models and technology innovation. Portable and easy-to-use IV devices are becoming a necessity with hospitals in demand for smart infusion pumps that not only connect with the digital platforms but also with electronic health records (EHRs) and remote monitoring systems. For instance, almost half of the hospitals, i.e., 46%, are going for the adoption of smart infusion pumps worldwide; thus, these connected devices that are lowering medication errors and improving safety are becoming a trend more and more prevalent. To date, AI-powered smart pumps from the likes of B. Braun whose main feature is real-time monitoring and improved safety have been the latest technological rollouts; this is vividly showing how innovation is not only bringing about new product categories but also new revenue streams. Expansion of home infusion therapy options partnered with telehealth and remote patient management is resulting in higher usage of small IV systems outside hospitals. All these trends open a strong window for the makers to grow by innovating and developing sophisticated, connected IV equipment that is suited for home care and digital healthcare systems simultaneously.

The " IV Equipment Market Size and Forecast (2022–2033)" report provides a detailed analysis of the market covering below areas:

• IV equipment market size and forecast at global, regional, and country levels for all the key market segments covered under the scope
• IV equipment market trends, as well as market dynamics such as drivers, restraints, and key opportunities
• IV equipment market analysis covering key market trends, global and regional framework, major players, regulations, and recent market developments
• Industry landscape and competition analysis covering market concentration, heat map analysis, prominent players, and recent developments for the IV equipment market
• Detailed company profiles, including SWOT analysis

The geographical scope of the IV equipment market report is divided into five regions: North America, Asia Pacific, Europe, Middle East & Africa, and South & Central America. The IV equipment market in Asia Pacific is expected to grow significantly during the forecast period.

The Asia-Pacific IV equipment market is segmented into China, Japan, South Korea, India, Australia, New Zealand, Indonesia, Malaysia, the Philippines, Singapore, Thailand, Vietnam, Taiwan, Bangladesh, and the Rest of Asia. The Asia-Pacific IV equipment market is experiencing robust growth, due to a number of connected factors based on the development of healthcare and demographic trends. One main reason for this is the healthcare infrastructure and investment in countries like China, India, Japan, and South Korea, which has led to a rise in hospital capacity and surgical volumes that require IV equipment like infusion pumps, catheters, and administration sets to a large extent. The governments of these countries are consistently providing support to healthcare in terms of access and quality, thus modernizing the facilities and leading to higher adoption of advanced IV technologies.

Another factor is the huge and increasing patient population suffering from chronic diseases like cancer, cardiovascular conditions, and diabetes who have become the mainstay of the IV therapy demand in both the inpatient and outpatient environments. The rising burden of patients with chronic diseases is proportionate to the increase in hospital admissions and thus the need for long-term IV treatment. Furthermore, the rapid pace of urbanization and the rising health consciousness among the people are aiding the utilization of IV therapy for three primary purposes: hydration, nutrition support, and drug delivery. The region's geriatric population has also contributed to the demand, as the elderlies usually need more frequent and complex medical care that involves intravenous interventions.

In combination with the increasing adoption of home healthcare and the demand for smart, portable infusion systems, these trends build a good environment for a strong IV equipment market growth in Asia-Pacific.

• The report includes qualitative and quantitative data in the IV Equipment Market across product, end user, and geography.
• The report starts with the key takeaways (chapter 2), highlighting the key trends and outlook of the IV equipment market.
• Chapter 3 includes the research methodology of the study.
• Chapter 4 further includes ecosystem analysis.
• Chapter 5 highlights the major industry dynamics in the IV equipment market, including factors that are driving the market, prevailing deterrents, potential opportunities, as well as future trends. Impact analysis of these drivers and restraints is also covered in this section.
• Chapter 6 discusses the IV equipment market scenario, in terms of historical market revenues, and forecast till the year 2033.
• Chapters 7 to 9 cover IV Equipment Market segments by product, end user, and geography across North America, Europe, Asia Pacific, Middle East and Africa, and South and Central America. They cover the market revenue forecast and factors driving the market.
• Chapter 10 describes the competitive analysis along with the heat map analysis for the key players operating in the market.
• Chapter 11 describes the industry landscape analysis. It provides detailed descriptions of business activities such as market initiatives, new developments, mergers, and joint ventures globally, along with a competitive landscape.
• Chapter 12 provides detailed profiles of the major companies operating in the IV equipment market. Companies have been profiled on the basis of their key facts, business descriptions, products and services, financial overview, SWOT analysis, and key developments.
• Chapter 13, i.e., the appendix is inclusive of a brief overview of the company, list of abbreviations, and disclaimer.

The IV equipment market is evaluated by gathering qualitative and quantitative data post primary and secondary research, which includes important corporate publications, association data, and databases. A few of the key developments in the IV equipment market are:

• In July 2022, B. Braun Medical Inc. launched the Introcan Safety 2 IV catheter, which consists of a single-time blood control mechanism. The new IV catheter provides higher safety for medical personnel by reducing the risk of needle-stick injuries and limiting their contact with blood during the catheter insertion process.
• In May 2023, Terumo revealed the establishment of an ultramodern production plant at its renowned Kofu Factory. The Medical Care Solutions company and its US$360 million investment made the next step in the sector.